Cuvposa Liquid
Product Images NDC 0259-0501

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cuvposa (NDC 0259-0501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merz Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cuvposa 01)

Chemical structure of glycopyrrolate, the active ingredient in Cuvposa oral liquid 1 mg/5 mL by Merz Pharmaceuticals, LLC. The diagram shows the molecular arrangement including rings, ester, and ether groups.*

FDA Label Image

Figure 1 (Cuvposa 02)

A line graph comparing the mean mTDS score over time between glycopyrrolate and placebo groups from baseline to week 8. The graph shows two lines with error bars indicating variability, with glycopyrrolate group scores decreasing over time and placebo group scores remaining relatively stable.*

FDA Label Image

Principal Display Panel (473 mL Bottle Carton)

Packaging label for Cuvposa (glycopyrrolate) oral solution, 1 mg/5 mL (0.2 mg/mL) strength. The label indicates it is an oral liquid prescription drug supplied in a 16 fl. oz. (473 mL) bottle. The labeler is Merz Pharmaceuticals, LLC, and it includes storage instructions and a barcode. Manufactured by Mikart, LLC, Atlanta, GA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.